Skip to main content
Log in

Further evidence for negative feedback control of serotonin release in the central nervous system

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

In the presence of the serotonin (5-HT) uptake inhibitor citalopram (2×10−5 M), 5-HT, added to the superfusion medium, diminished the electrically induced 3H-overflow from rat cortex slices prelabelled with 3H-5-HT. A 50% decrease of the 3H-overflow was obtained with 6×10−7 M 5-HT. Of the 5-HT antagonists tested (methysergide, methergoline, methiothepin, cyproheptadine, cinanserin, mianserin, pizotifen), methiothepin (50% at 4.5×10−7 M), methergoline (31% at 10−6 M) and cinanserin (30% at 10−6 M) increased the stimulation-induced 3H-overflow. In some experiments the overflow of endogenous 5-HT was measured simultancously with 3H-overflow. The results were qualitatively and quantitatively very similar, indicating that 3H-overflow can be taken as a reliable measure of 5-HT release. The existence of a functional negative feedback control of 5-HT release mediated by presynaptic autoreceptors was confirmed by analysis of the 3H-overflow per pulse at stimulation frequencies between 0.1 and 50 pulses per second (pps). The 3H-overflow per pulse decreased with increasing stimulus frequency, reaching a low level at 1.6 pps corresponding to 30% of the initial value at 0.1 pps. Methiothepin did not increase the stimulation-induced 3H-overflow at 0.1 pps. The stimulation-induced 5H-overflow at 0.1 pps in the absence of methiothepin was equivalent to that at 1.6 pps in the presence of methiothepin. These results suggest that, under the given experimental conditions, at a stimulation frequency of 0.1 pps the 5-HT concentration in the synaptic cleft drops to very low levels, barely sufficient to induce negative feedback. Among a variety of drugs tested, LSD, dimethyltryptamine, m-chlorophenylpiperazine and clonidine decreased the stimulation-induced 3H-overflow, whereas salbutamol, propranolol, oxprenolol, spiroperidol and haloperidol had no effect. Quipazine, known as a 5-HT agonist, unexpectedly augmented the stimulation-induced 3H-overflow. This effect might be attributable partly to its 5-HT uptake inhibiting component, and also to blockade of presynaptic 5-HT receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahtee L, Sharman DF, Vogt M (1970) Acid metabolites of monoamines in avian brain: effects of probenecid and reserpine. Br J Pharmacol 38:72–85

    Google Scholar 

  • Baumann PA (1980) Presynaptic serotonin autoreceptors in rat cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 311:R71

    Google Scholar 

  • Baumann PA, Koella WP (1980) Feedback control of noradrenaline release as a function of noradrenaline concentration in the synaptic cleft in cortical slices of the rat. Brain Res 189:437–448

    Google Scholar 

  • Baumann PA, Maître L (1977) Blockade of presynaptic-α-receptors and of amine uptake in the rat brain by the antidepressant mianserin. Naunyn-Schmiedeberg's Arch Pharmacol 300:31–37

    Google Scholar 

  • Bischoff S, Bittiger H, Krauss J (1981) In vivo 3H-spiperone binding to the rat hippocampal formation: Involvement of dopamine receptors. Eur J Pharmacol (in press)

  • Bourgoin S, Artaud F, Enjalbert A, Héry F, Glowinski J, Hamon M (1977) Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotonergic receptors during ontogenesis in the rat. J Pharmacol Exp Ther 202:519–531

    Google Scholar 

  • Cerrito F, Raiteri M (1979) Serotonin-release is modulated by presynaptic autoreceptors. Eur J Pharmacol 57:427–430

    Google Scholar 

  • Chase TN, Katz RI, Kopin IJ (1969) Release of 3H-serotonin from brain slices. J Neurochem 16:607–615

    Google Scholar 

  • Christensen AV, Ejalland B, Pedersen V, Danneskjold-Samsoe P, Svendsen O (1977) Pharmacology of a new phtalane (Lu 10-171) with specific 5-HT uptake inhibitory properties. Eur J Pharmacol 41: 153–162

    Google Scholar 

  • Clineschmidt BV, Totaro JA, Pflueger AB, McGuffin JC (1978) Inhibition of the serotonergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine). Pharmacol Res Commun 10:219–228

    Google Scholar 

  • Creese I, Snyder SH (1978) 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 49:201

    Google Scholar 

  • Dunnett CW (1955) A multiple procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121

    Google Scholar 

  • Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20:482–491

    Google Scholar 

  • Farnebo LO (1971) Release of monoamines evoked by field stimulation —Studies on some ionic and metabolic requirements. Acta Physiol Scand (Suppl) 371:19–27

    Google Scholar 

  • Farnebo LO, Hamberger B (1971a) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand (Suppl) 371:35–44

    Google Scholar 

  • Farnebo LO, Hamberger B (1971b) Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Br J Pharmacol 43:97–106

    Google Scholar 

  • Farnebo LO, Hamberger B (1974) Drug-induced changes in the release of 3H-monoamine from field stimulated rat brain slices. J Pharm Pharmacol 26:642–644

    Google Scholar 

  • Fillion GMB, Rousselle JC, Fillion M-P, Beaudoin DM, Goiny MR, Deniau JM, Jacob JJ (1978) High-affinity binding of 3H-5-hydroxytryptamine to brain synaptosomal membranes: Comparison with 3H-lysergic acid diethylamide binding. Mol Pharmacol 14:50–59

    Google Scholar 

  • Fuller RW (1980) Pharmacology of central serotonin neurons. Ann Rev Pharmacol Toxicol 20:111–127

    Google Scholar 

  • Fuller RW, Snoddy HD, Perry KW, Roush BW, Molloy BB, Bymaster FP, Wong DT (1976) The effects of quipazine on serotonin metabolism in rat brain. Life Sci 18:925–934

    Google Scholar 

  • Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230

    Google Scholar 

  • Göthert M, Weinheimer G (1979) Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 310:93–96

    Google Scholar 

  • Grabowska M, Antkiewics L, Michaluk J (1974) The influence of quipazine on the turnover rate of serotonin. Biochem Pharmacol 23:3211–3212

    Google Scholar 

  • Green AR, Youdim MBH, Grahame-Smith DG (1976) Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism. Monoamine oxidase activity and behaviour. Neuropharmacology 15:173–179

    Google Scholar 

  • Hamon M, Bourgoin S, Jagger J, Glowinski J (1974) Effects of LSD on synthesis and release of 5-HT in rat brain slices. Brain Res 69:265–280

    Google Scholar 

  • Hamon M, Bourgoin S, Enjalberg A, Bockaert J, Hery F, Ternaux JP, Glowinski J (1976) The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 294: 99–108

    Google Scholar 

  • Hong E, Sancilio LF, Vargas R, Pardo EG (1969) Similarities between the pharmacological actions of quipazine and serotonin. Eur J Pharmacol 6:274–280

    Google Scholar 

  • Jacoby JH, Howd RA, Levin MS, Wurtman RJ (1976) Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism. Neuropharmacology 15:529–534

    Google Scholar 

  • Jenner P, Marsden CD, Thanki CM (1980) Behavioral changes induced by N′N-dimethyltryptamine in rodents. Br J Pharmacol 69:69–80

    Google Scholar 

  • Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272:168–170

    Google Scholar 

  • Lowry OR, Rosebrough NJ, Farr AL, Randall EJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Middlemiss DN, Blakeborough L, Leather RS (1977) Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptors. Nature 267:289–290

    Google Scholar 

  • Ortmann R, Radeke E, Delini-Stula A (1980) Interaction of salbutamol with the serotonergic system in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 311:R280

    Google Scholar 

  • Ponzio F, Jonsson G (1979) A rapid and simple method for the determination of picogram levels of serotonin in brain tissue using liquid chromatography with electrochemical detection. J Neurochem 32: 129–132

    Google Scholar 

  • Quock RM, Beal GA, Chan ELF (1976) Quipazine: A serotonergic hyperthermic agent in the rabbit. J Pharm Pharmacol 28:170–172

    Google Scholar 

  • Rodriguez R, Rojas-Ramirez JA, Drucker-Colin RR (1973) Serotoninlike actions of quipazine on the central nervous system. Eur J Pharmacol 24:164–171

    Google Scholar 

  • Rokosz-Pelc A, Antkiewicz-Michaluk L, Vetulani J (1980) 5-hydroxytryptamine-like properties of m-chlorophenylpiperazine: Comparison with quipazine J Pharm Pharmacol 32:220–222

    Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    Google Scholar 

  • Starke K, Montel H (1973) Involvement of α-receptors in clonidineinduced inhibition of transmitter release from central monoamine neurons. Neuropharmacology 16:1073–1080

    Google Scholar 

  • Waldmeier PC (1981) Stimulation of central serotonin turnover by β-adrenoceptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol (in press)

  • Weinstock M, Weiss C, Gitter S (1977) Blockade of 5-hydroxytryptamine receptors in the central nervous system by β-receptor antagonists. Neuropharmacology 16:273–276

    Google Scholar 

  • Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baumann, P.A., Waldmeier, P.C. Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 36–43 (1981). https://doi.org/10.1007/BF00506254

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00506254

Key words

Navigation